Carmell Co. (NASDAQ:CTCX) Sees Significant Growth in Short Interest

Carmell Co. (NASDAQ:CTCX) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 827,600 shares, a growth of 688.2% from the December 15th total of 105,000 shares. Based on an average daily volume of 10,930,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 6.1% of the shares of the company are short sold.

Carmell Price Performance

Shares of CTCX stock traded up $0.06 during trading hours on Monday, reaching $0.55. The stock had a trading volume of 652,582 shares, compared to its average volume of 47,532,453. The stock’s fifty day simple moving average is $0.30 and its 200 day simple moving average is $0.62. Carmell has a 12 month low of $0.20 and a 12 month high of $4.00.

Hedge Funds Weigh In On Carmell

A hedge fund recently bought a new stake in Carmell stock. Warberg Asset Management LLC acquired a new stake in Carmell Co. (NASDAQ:CTCX) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned 0.22% of Carmell at the end of the most recent quarter. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.